Guy Levy Insider Profile
4 Followers
Guy Levy, Ten Percent Owner at Parabilis Medicines, Inc., holds 527.07K shares in Parabilis Medicines, Inc. (Ticker: PBLS), holds 2.52M shares in BioAtla (Ticker: BCAB). Most recently, Guy Levy Bought ― shares of Parabilis Medicines, Inc. on Jun 29, 2026 for an estimated value of $5.00M.
Guy Levy Parabilis Medicines, Inc. (PBLS)Ten Percent Owner
Parabilis Medicines, Inc. (PBLS)
Ten Percent Owner
Ranked #7,992 out of 108,921 Corporate Insiders
Profitable Transactions
5 out of 5 Profitable Transactions
Average Return
+51.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Guy Levy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Guy Levy
Guy Levy's Trading History
Parabilis Medicines, Inc.
Jun 29, 2026
Ten Percent Owner
Informative Buy
5.00M
$20.96M
BioAtla
Sep 30, 2021
Former Director
Uninformative Buy
7.50M
$3.17M
List of latest transactions for each holding click on a transaction to see Guy Levy's performance on stock
You May Also Like
Guy Levy insider profile FAQ
What is the percentage of profitable transactions made by Guy Levy?
The percentage of profitable transactions made by Guy Levy is 100%.
What is the average return per transaction made by Guy Levy?
The average return per transaction made by Guy Levy is 51.90%.
What stocks does Guy Levy hold?
Guy Levy holds: PBLS, BCAB stocks.
What was Guy Levy’s latest transaction?
Guy Levy latest transaction was an Informative Buy of $5.00M.
What was Guy Levy's most profitable transaction?
Guy Levy’s most profitable transaction was an Informative Sell of BCAB stock on June 21, 2021. The return on the trade was 92.70%.
What is Guy Levy's role in Parabilis Medicines, Inc.?
Guy Levy's role in Parabilis Medicines, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.